文献速递眼底病与葡萄膜炎

PCARE相关视网膜病变——遗传学、临床特征与自然史

PCARE-Associated Retinopathy - Genetics, Clinical Characteristics, and Natural History.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

这项回顾性队列研究纳入28例(56眼)PCARE变异相关遗传性视网膜病变患者,描述其突变谱、临床特征与自然史。视网膜表型为严重弥漫性光感受器营养不良伴黄斑萎缩,黄斑保留丧失与视力恶化相关,法定盲中位年龄57岁,作者认为最佳治疗窗口似在50岁前。

要点

  • PCARE相关视网膜病变表现为严重弥漫性光感受器营养不良,所有患者均有黄斑萎缩。
  • 黄斑保留丧失(中位年龄45岁)与最佳矫正视力平均恶化1.1 logMAR相关(95%CI 0.6至1.5,P<0.001)。
  • 较好眼低视力与盲的中位年龄分别为50岁和57岁,作者认为最佳治疗窗口似在50岁前。

核心结论

  • PCARE相关视网膜病变是一种严重的弥漫性光感受器营养不良伴黄斑萎缩。
  • 尽管视野丧失出现较早,但黄斑保留使有用中心视力常保留至成年晚期。
  • 基于法定盲发病年龄,作者认为最佳治疗窗口似在50岁前。

研究设计与样本

  • 回顾性队列研究,纳入28例(56眼)PCARE变异相关遗传性视网膜病变患者。
  • 主要结局指标为最佳矫正视力(BCVA)与视力损害程度、以V4e视标界定的动态视野(KVF)面积、短波长自发荧光上肯定性自发荧光减低(DDAF)的黄斑萎缩(MA)面积、光学相干断层扫描上的总黄斑体积(TMV)与黄斑保留(FS)。

主要发现

  • 首次检查中位年龄40.7岁(四分位距28.8至49.6),中位随访时间5.7年(四分位距3.6至7.1)。
  • 所有患者均有黄斑萎缩,85%的眼观察到DDAF病灶。
  • 黄斑保留丧失发生的中位年龄为45岁,与BCVA(logMAR)平均恶化1.1相关(95%CI 0.6至1.5,P<0.001)。
  • 较好眼低视力和盲发生的中位年龄分别为50岁和57岁。
  • 纵向分析显示BCVA(logMAR)每年恶化0.06(95%CI 0.03至0.09,P<0.001),KVF面积每年减少23%(95%CI -35%至-12%,P=0.004),平方根转换的DDAF面积每年扩大0.20 mm(95%CI 0.16至0.23,P<0.001),TMV每年下降0.015 mm3(95%CI -0.023至-0.007,P=0.003)。

关键数值与推荐

  • 鉴定出11个新的PCARE变异。
  • 黄斑保留丧失的中位年龄为45岁,较好眼低视力和盲的中位年龄分别为50岁和57岁。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to describe the mutational landscape, clinical characteristics, and natural history of PCARE-associated retinopathy. METHODS: Retrospective cohort study including 28 patients (56 eyes) affected by an inherited retinal disease related to PCARE variants. The main outcome measures were best-corrected visual acuity (BCVA) and degree of vision impairment, kinetic visual field (KVF) area delimited with the V4e target, area of macular atrophy (MA) with definitely decreased autofluorescence (DDAF) on short-wavelength autofluorescence, total macular volume (TMV) and foveal sparing (FS) on optical coherence tomography. RESULTS: The median age at first examination was 40.7 years (Interquartile range [IQR] = 28.8-49.6), whereas the median follow-up time was 5.7 years (IQR = 3.6-7.1). The retinal phenotype was consistent with a severe generalized photoreceptor dystrophy with MA in all patients. DDAF lesions were observed in 85% of the eyes. Loss of FS (occurring at a median age of 45 years) was associated with a mean BCVA (logMAR) worsening by 1.1 (95% confidence interval [CI] = 0.6 to 1.5, P < 0.001). Low vision and blindness in the better-seeing eye occurred at median ages of 50 and 57 years, respectively. Longitudinal analysis revealed the following mean slopes of change: BCVA (logMAR) worsened by 0.06/year (95% CI = 0.03 to 0.09, P < 0.001), KVF area decreased by -23%/year (95% CI = -35% to -12%, P = 0.004), square root-transformed DDAF area expanded by 0.20 mm/year (95% CI = 0.16 to 0.23, P < 0.001), and TMV declined by -0.015 mm3/year (95% CI = -0.023 to -0.007, P = 0.003). Eleven novel PCARE variants were identified. CONCLUSIONS: PCARE-associated retinopathy is a severe generalized photoreceptor dystrophy with MA. Although visual field loss occurs early, useful central vision is often retained into late adulthood because of FS. Based on the age of onset of legal blindness, the optimal therapeutic window appears to be before the fifth decade of life.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Bianco L, Antropoli A, Benadji A, et al. PCARE-Associated Retinopathy - Genetics, Clinical Characteristics, and Natural History. Invest Ophthalmol Vis Sci. 2025. PMID: 40261664. doi:10.1167/iovs.66.4.61

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。